Prognostic value of minimal residual disease detection by multiparameter flow cytometry (EuroFlow method) in patients with multiple myeloma who underwent autologous stem cell transplantation: comparison with sequencing-based method
Not Applicable
- Conditions
- multiple myeloma
- Registration Number
- JPRN-UMIN000022238
- Lead Sponsor
- Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who the physicians in charge judge to be inappropriate to participate in this trial.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The correlation of MRD levels between BML-Flow and original EuroFlow methods.
- Secondary Outcome Measures
Name Time Method 1)1-year PFS post-ASCT and 3-year PFS post-ASCT 2)1-year OS post-ASCT and 3-year OS post-ASCT 3)MRD negative rate in BM post-ASCT